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1.

Shock may be described as a syndrome of peripheral
vascular i!'l..8ufficiency :In v1hich the effective circulatir.:.g
blood volwne is reduced, accompanied by depression of many
systems.

The impaired general cir'culation causes diminished

tissue perfusion and

26

ion.

decomper~ation

of the microcirculat-

The result is a basic defect in cellular perfusion.

Although the etj. ology and mechanism of shock may vary, the
final common physiological lesion is cellular hypoxia.
Hemorrhage or another type of metabo11.c insult may be the
initial lesion, but regardless of etiology all types of
shock rapidly form a similar syndrome since they sbEvre the
same basic defect of cellular l1Ypoxia.
Haldane,
th~1

30

56

As stated by

uAnoxia not only stops the machine, rrut v;rrecks

machiner"'lJ. II
Hemorrhagic shock has been a misunderstood and

frequently mistreated clinical syndrome.

It is a complex

entity that involves many etiologic factors, and becomes
more complicated when

combin~tions

of these factors are

the causes of circulatory collapse.
shock has increased steadily over the
has improved our

understandir~

phYSiologic mechanisms.

Know·ledge concerning
yeal~

as research

of basic biochemical and

New research tools and advanced

methods of monitoring phYSiologic parameters have also
allOilfed a more scient:tflc approacrl to understanding the
mechanisms and management of hemorrhagic shock.
the

gro·~rth

HOvfever,

of concepts leading to the present understand-

i11;5 of shock requires an appr'eciation of the historical

\.,~

2.

background involved.

HISTORY
The early defir..itiol1..8 of shock were based entirely
on clinic1:;11 description and the initial usage of the term
arose from observation of the l'lounded. on the battlefield.

60

Shock 1,'1as used to denote a condition l"here the injury, on
superficial examina.tion appeared too small to account for
the seeming collapse of vital processes.
definition of shoo1r,

If

Warren's

58

A momenta!"'J pause in the act of

death," implies that the study of shock is the study of
impending death.

Gradually the prostration, hypotension,

pallor, coldness, moisture of the skin, collapse of superficial veins, suppression of urine formation, and obtunded.
mental status seen in battle casualties came to be recognized in other conditions such as cholera.

In 1831 Latta

made a monumental contribution to the u-1'lderstandi!l(£ of
sl1.ock.

1j"ithout :r:n"'ecedent to direct him he proceeded to

infuse 330 ounces of saline intravenously into a cholera
patient in 12 hours, and reported dramatic clinical
improvement.
The advent of experimental physiology and the use of
the kymograph focused attention on the measurement of
arterial blood pressure, and confinaed that hypotens:ton
iias one of the most con...l:3istent accompaniments of shock.
Recogn 1 tion of the control of the heart and blood vessels
by a vasomotor center acting by itTaY of nervous p'3.th"kiays

37

.

prompted the concepts of vasomotor paralysis and of' cardiac
failure resulting from reflex vagal hyperactivity.

'rhis

neurogen1. c definition of' shock '\tras summarized by
Groenigen

27

in 1885.

He proposed that shock began as

a state of intensive nervous stimulation and was followed
by vasomotor exhaustion.
At the end of the 19th centu17 Crile

15

an experimental model of hemorrhagi.c shock.

developed
His 1tfork

resulted in a systematiC definition of shock in the
experimental animal.

He clearly documented the lowered

venous pressure ln hypovolemic shock, the accelers.tion
and deepening of respiration follol'ling hemorrha,ge and the
response of the shocked animals to infusion of warm saline.
This latter

respon.~e

w'as an indj.oation to Cri.le that the

oardiac aotion was normal in shock and that the defeot
was largely one of impaired venous return.
'ilar has almost invariably stimulated interest in the
definition and therapy of shock, and the war of 1914-1918
was no exception..

From observations made on the battle12
field and in laboratory investigation, Cannon
attempted

to explain the hypotenSion of shock in terms of cardiac
failure, loss of vasomotor tone, fall in blood volume,
or stagnation in venous reservoirs.

In 1917 CarJlon used

the then nei<l Van Slyke apparatus to document a correlation
bet1.'feen the
reserve.

10"\1

blood pressure and the reduction i.n alkali

He believed that the fall in the alkali reserve

'vms due to t,he accumulation of fixed acids, such as lactic

4.

acid, and recognized that this "\vas due to impaj,red oxygen
transport.

The acidosis

"faS

:ldentified as a secondary

phenomenon that "\,las responsive to the adminj.stration of
sodium bicarbonate.

When the volwue of the war wounded

'{vaS studied by means of dye dilution methods, it

",'faS

found that the severity of shock correlated '!tlith the
reduction in blood volume.

Cannon then deflned "\1ound

shock as a discrepancy between blood volume and vascular
capacity.
Other vlorkers continued to add to the body of knovlledge dur:lng the follo . ..,ing years.

Recent investigations

have concentrated largely on the elucidation of the
hemodynamic and biochemical events in experimental canine
models using endotoxin or graded hemorrhage.

29,35,40

AlthOugh a considerable body of knowledge has emerged
from this vlOrk, much cannot be transposed readily from
the artificlal experimental model to the clinical situation.
The comulexities of human shock are in reality poorly
. 60
The age of the patient, past medical
defined.
history, possibility of severe underlying disease, and
the function of vltal organs are varil;;1.ble factors that
may contrlbute to ci,rculatory collapse.

All this infor-

mation is not readily quantitatable nor transferable from
one case to another, but is vital in the interpretation
and analysls of shock data.
Tradit:i.onally, physicians regard shock from the
circulatory vle'dpoint.

Blood pressure, heart rate and

5.

venous pressure are the three most readily measured, and
hence, the most COlUill0nly cons idered variables.

Hm1ever,

an absolute value of any one par1.;tmeter i.s seldom a
satisfactory basis for determining the presence or the
severity of shock.

Shock has often been regarded as a

problem in arteril3.1 pressure \'lh(:;n in fact a more satisfactory common denominator ';10uld appear to be cellular
d~~age

due to inadequate capillary flow and resulting

hypoxia.

2,56

While a falling blood pressure is almost

invariable in shock, the hypoten.gion mtlY be a relatively
late development in the course of events.

Similarly,

"",lhile the degree of hypote!'l..sion often correlates vdth the
sever:i.ty of the shock, there may be exceptions.

Conversely J

in severely shocked patients the blood pressure may be
raised 1dth vasopressors to normal or hypertensive levels,
but the tlssue blood floN' is progressively reduced.

21,31,32

Distribution of blood flO'1'1 to nutritive or non-nutritive
vessels is just as important as al"1:.erlal pressure or
cardiac output.
In :tts Simplest form shock is largely a problem of
blood gas transport and exchange at the pulmonar;:y- and
cellular levels.

Although cellular disorganization

produced by a prolor"ged decrease in blood fl0i1 may ori13inate from the breakdovll'l of mitochondrial enzyme systems
or the release of hydrolases from lysosomes, it must be
recognized clinically as a decrease in the function of
an orGan system such as the myocardium, the kidney, or

6.

the lun.gs.

Improvement in the CH,re of the shock pat ient ,

therefore, can be achieved by close and continuous observation of the patient and the changing clinical picture,
repeated measurements of organ system functions by available
techniques, and the appropriate use of fluids, solutes,
and drugs.

The 011f1..ical mftnagement of shook demands

unremi,tt1ng personal attent::Lon beoause of the need to
oontinuously monitor and treat hypovolemia, respiratory
disorders, myocardial

decom;~~el1satiol1,

renal failure and

so forth.

PATHOPHYSIOLOGY OF SHOCK
An understanding of the changes result:Lng in the

progreSSion of events
for proper therapy.

resultin~

]"lany of the

and val""iable, depending upon the

in shock is essential
cha~'3es
eA~ent

are time related
of the injury.

In hemorrhagic shock the primary problem is hypovolemia
or decreased effective circulating blood volume.
There is decreased venous return.

2,18,50

17,55

Cardiac output is decreased and the arterial blood
pressure falls causing stimulation of baroreceptors.

This

results in an increased heart rate and the myocardium
2,16
contracts "'lith increased force.
31
Decreased capillary blood flow occurs.
l"'nere is neuroendocrine stimulation resulting in
release of antidiuretic hormone and adrenocoticotropic
'+2
hormone.
The output of l7-bydroxycortico1d, aldosterone

and catecholamines is increased.
mechanism is activated.
tion are produced.

The renin-angiotensin

Arterial and venous

vasocor~tric-

Hepatic glycogen breakdm'ln is stimulated

producing hyperglycemia and eventually hyperkalemia and
glycogen depletion.
stages, since

Hypoglycemia may occur in terminal

hist~m.ine,

serotonin, and vasoactive

polypeptide release may increase.
Available cardiac output to skin, skeletal muscle,
kidneys, and the splancrillic bed is reclistri buted by both
arteriEd and venous vasoconstri,ction to the central
circulation, especially the heart and brain.
Capillary refillir..g of plasma volume occurs Hith
3
resuTting hemodilution. Adrenal steroids and the renil"lan~$iotensin

mechftnism may part'Jicipate in thi.s refilling.

Hyperventilation occurs.

14

Initially this is probably

secondary to decreased central nervous system blood flow.
Respiratory alltalosis may follow the initial hyperventi.lation and further decrease cerebral blood flow' by a fall
in arterial pC02 •

Later, hyperventilation from metabolic

acidosis occurs.
Cellular hypoxia, decreased aerobic oxidation through
the Krebs tricarboxylic acid cycle and the electron
transport system and an increa.se in anaerobl,c glycolysis
by the Embden-Meyerhoff pathway occurs.

2,9,52

Blood

levels of lactate and PYl41Vate are both increased initially,
34
but later, blood lactate increases more 'tr..an PYr'..lvate.
Increased acid metabolites produce metabolic acidosis and

8.

blood :pH and carbon dioxide content fall.
Tissue adenosine triphosphate stores decrease, and
levels of inorganic phosphate increase.

Glucose utilization

is decreased, and alpha amino nitrogen levels increase.

52

Hyponatremia and hyperltalemia are produced.
There j.s depression of the reticuloendothelial system
'Vlith decreased phagocytosis.

Sludgil1..g and intravascular

red cell aggregation may occur.

31,32

There may be morphologiC intracellular changes of
cytoplasm ''lith edema and rni tochondrie.l disorganization
as well as increased levels of lysosomal hydrolase enzT&es
t:;?
-,-

and proteases in peripheral blood.
Regional vasodilatation and pooling of blood 2clong
itlith the other changes eventually lead to cell death.
The e1'fects of hemorrl1age and decreased. blood 1'10111 on
various organs can be discussed only in general terms ..
In the individual patient, these

~vill

depend on the pres-

ence of pre-existing organ or vascular d:tsease.

Hovlever,

every organ participates in the shock syndrome by altering
its function as a defense against the metabolic insult ..
During shock, rel'lal blood

1'1011

is decreased due to

vasoconstriction of the reIk'll arteries.

There :i.s an

intrarel1£l.l redistribution of blood flo,,! from the cortex
favoril1.g the medulla.
rate and

oillgur:le~

A decreased glomerular filtratiol1

are noted.

below 30 milliliters.

Hourly urine volumes fall

There is a decrease in

medulla~J

sodium vIith loss of the medullary hyperosmolar zone and

loss of the countercurrent

concentratir~

system.

of the renin-ane3iotensin mechanism occurs.

Activation

Eventually

tubular necrosis accentuated by pigment excretion of

azotemia, hyperkalemia, and acidos:i..s occurs •

16
The initial ctlrd1ac response is a decrease in output.
The nonnal heart responds to ch;:tnging venous return by
caro:i.etc output adjustments, and over significant periods
the venous return must equal ca.rdiac output.

vlhen he111or-

rhage has occurred, venous return is altered by peripheral
factors (c or...strict ion, aggregation) as 14'ell as by the
volume lost, and cardiac output falls in
diL1inished venous return.

respol~e

to

This is counteracted by the

pressure receptors in the aortic

e~rch

and the carotid sinus

VJ'hich, 1n response to hypotension, induce a reflex increase
in heart rate and stroke volume.

The coronary circulation

has an extraordinary capacity for oX'.rgen extraction, but

e~t

101.'1 pressure levels it may not be able to deliver sufficient
oxygen to the myocclrdiu.m to maintain contractility.
Endogenous norepinephrine 'dill increase myocardial contractile force, but 1'iill also increase the oxygen requj"re2

ments of the myocardium.

Acidosis may cause further

deterioration of myocardial function.

Pre-existing coronary

artery disease may lead to myocardial ini'arction.
Decreased pu]monary blood flow may contribute to
1+6
hypoxia and carbon dioxide retention.
As shock progresses
there is a loss of pulmonary elasticity clue to the

10.

sequestration of flu::td in the interstital space and
increased capillary permeability 'fiith pulmonary edema.
Sequestration of red blood cells and intravascular coagulation within the pulmonary capillaries may occur.

31

In the liver there 1s a marked reduction in the stores
of adenosine triphosphate and decreased ability to break
down lactate and detoxify other substances.

Decreased

blood flo'Vl to the gastrointestinal tract during shocl<::
results in mucosal ischemia and a decrease in mucin
production i'lhlch favors peptic ulceration.
The changes occuring after

hemorrha~e

have been extensively studied by Moore.

44

in normal man

F.ECOGNITION

Pure hemorrhage is a frequent cause of shock in massive
gastrointestinal bleedin.,.g, penetrating

tr:~n.lIlla

Ivi th injury

to solid viscera such as liver, spleen, kidney or artery,
r . . lptured aneurysm, etc.

The clinical findings in the

resulti!'l.g hypovolemic shock are based largely on generalized vasoconstriction in the periphery
volume return to the right heart
output.

1.;1 th

al1d

diminished

decreased cardi.ac

The effect of excess endogenous vasopressors

explair...s the cool, clammy skin "tli th sympathetic overactivity.

Similarly, tachycaroia, tachypnea, and diastolic

hypertension are signs of maximal peripheral res:'Lstance
compe!'l..sating for the early modest decrease in cardiac
output.

HO'ti'ever, continued fall in cardiac output causes

11.

arterial hypotension unless treatment is undertaken.
Olinical assessment of the magill tude of the hemorrhage is useful in planning therapy.

The capillary blanch-

ing test is performed by blanching the skin of the forehead
or

hypothe!'..:~r

eminence t'Jr thumb pressure; normal cutaneous

circulation '('ii11 return in 1.25 to 1.5 seconds.

Delay in

refill is a crude :i.ndication of 20 per cent blood vol'lune
deficit or greater.

Patlents in frank shock either have

insufficient cutaneous circulation for blanching to be
evj.dent, or demonstrate marked delay in refill.
f::;uide to the

13 cope

Another

of the bleed:'Lng Vlhich has occurred has

to do vdth having the patient sit up suddenly; "1hen blood
losses 1.n excess of 15 per cent of circulati:ng volU!1J.e exist,
sudden cerebral j.sohemia vlith dizziness, nausea or faintir..g
f0110",IS assumption of the upright position.
The f011ov1ing maneuvers may be undert'iken IiThen a pat:tent
:i.s admitted to the hospital vlith massive bleedlllJ! :
'"'"'

1. Intravenous catheter(s) inserted.
2. Blood to be typed and cross-matched is obtninQd.
~?

Fluid a,nd solute relJlacement is st8"ried.

11-.

Urinar'"j bladder cathetel'" is inserted and hourly urine
volUrll.e measured.

5. Nasogastric tube is pl?3.ced

~l.f

source of bleeding is

obscure.
6. Vital signs including pulse pressure are measured and
recorded at speclflc lntern.rals.

7. Extent of

trau~a,

if any, :ts evaluated.

12.

8. Hematocrit is obtained.
volu..'1H~

lilay cor....gider obtaining blood

if available.

9. Central venous pressure catheter is inserted if not
previously done as IX:trt of 1. above ..

CElfrR.liL VENOUS PRESSm":tE

!~orn:frORING

A valuable 8,sset in the diagnosis and treatment of
shock :i.s a central venous catheter--a large ca.liber plastic
catheter inserted into tl1e superior vena cava by way of the
antecubltal, e:r;:terne"l jugu.lar or subclavian vein.
VenO"LlS pressure measurement,

alont~

Central

vlith arterial blood

pressure ,:lnd urine output measu.rements, has greatly improved
2

the care of the patient in shock.

A..'I1 inferior vena cava.

catheter influenced by abdominal pressure or a catheter in
the vein of an extremity do not accurately reflect right
atrial pressure, and are not suitable for monitoring central
venous pressure.

The catheter can be used for fluid

administration and blood sampling in addition to pressure
measurements.
A central venous :pressure catheter should be used
"\'lh,enever a pa,tient does not respond rapldly to "That is
believed to be adequate replacement of vascular volume.
Normal right atr:tal pressure is zero to 10 centimetel"S of
'\f8,ter or 2 to 8 millimeters He;.

If' a patient does not

respond satisfactorily to VOlUjl1e replacement and the central
venous pressure 1s low, volume restoration should be
continued u.."'ltll the central venous pressure begins to rise.

13.

It is difficult to give an absolute level tl1,;:\.t can be
used as an end point, but 15 centi.meters of 1'later or above
indicates begim1.ir...g circulatory overload.

This is usually

due to myocardial failure and is not a reflection of
hypertlolend.a.

How'ever, additional fluid administration

must be carefully cons:Ldered..

Other measures such as

dlg:Ltalis, other drugs having an inotropic cardiac effect,
or vasodi,lator agents may be required.
central venous pressure

monitorir~

13

The subject of

has recently been

8
revi el4'ed by BOrr0'll1 and Es oa1"'0 •
Patients requir:Lng positive pressure venti.lation may
ha:ve an elevated central venous pressure on this basls,
~

with persistent

t~rpovolemia.

Central venous pressure

may also be normal or high in hypovolemic patients if there
is poor

coronal~ arte~J

perfusion decreasing right

ventricular function.

As

by volume

central venous pressure may fall.

re~placement,

corona_~J

perfUSion is improved

There are other causes of a false elevation of central
venous pressure 1tlhlch must be kept in mind: mechanical
obstrtlction of the venous retul"n, as seen in cardiac
tampor.,ade, mediastin.:-'ll compression, or venous thrombosis;
hemothorax !J.nd pneumothorax; the administration of vasoconstrictors; and impro'per placement of the catheter.
"fl,ll of these fact ors \vil1 produce a. high central venous

pressure.

REPLACEr.rEIIT OF BLOOD, FLUID lU\T!) VOLUME

14.

Hypovolemia must be considered initially vlith shock
from any cause, since fluid or blood administration may
be heplful even if no losses are suspected or can be
1

documented.

A helpful concept that has evol...,red j"s to achieve

an effective circulating blood volume.

It is the best

e,-uide to the volume of blood and fluids needed, and one
of' the most common problems in the treatment of shock
caused by hypovolemia is inadequate volume replacement.
23,21+
The vascular space is not a static volume.
Vasoconstriction of resj.stance vessels, terll1inal arterIes
ELnd arterioles, may divert blood from various regions, but
the largest change in vascular bed volume probs.bly occurs
in capacitance vessels, the capillar:les, venules, and
veiX'..s.

Constriction of capacitance vessels in shock reduces

the peripheral vascular volume and increases the central
volume to a variable extent.
Treatment is best based on giving enough volume
replacement to achieve a reasonable arterial blood pressure,
good urine output, and good peripheral perfUSion as judged
by palpable peripheral pulses and lilarm, dry skin vlithout
ele~qE;<tion

of ri{;,.'1t atr:tal pressure.

This represents an

effective circulating blood volume.
The significance of a median venous pressure, 6 to 10
centimeters of "\vater, can be determined by a test infusion
of fluid.

An electrolyte solution 1s

a&~inistered

fairly

rap1"dly and the centrEtl venous pressure is measured after
every 100 cubic centimeters of fluid has been administered.

15.

If the central venous })ressure does not increase ;nore than

5 centimeters during the i,ni'usion of the first 500 centimeters
and returns to i'lithin 2 to 3 centimeters after 15 minutes
of
the

infus~. Qn,
j . ncrease

required.

th:l.s '"IQuld suggest th1:tt the heart tolerates
\1"ell and tha.t further fluid is most likely

On the other hand, an increa.se in central venous

pressure ''lould indicate that the heart is not capable of
handlip~

these additional quantities of fluid.

Estimc'ltion of blood loss follo\'liJ:"l..g trauma. is cllfficult.
RiddeXl loss after injury, particularlyvrlth fractures of
the femur or pelvis and 'IIith retropel"itoneal hematomas, often
escapes attention.

Replacement is better based upon

achieving an effective clrculatlng blood volLUlle than
upon attempts at calculation 'l,,ri th a bala.nce sheet.
Volume replacement should be provided as rapidly as
it is needed and tolerated.

The ul"gency of fluid or blood

administratiol1. to the hypovolemic patient must be stressed,
since the longer shock persists, the more devastating its
effect and the more difficult treatment becomes.

Isotonic

saline, Ri~'5erts lactate solution, or clini.c'O'"l dextran can
be given \"1h11e blood is belng 'Jroperly cross-matcheo.•
CHv1ng such fluids in the interim period1!1ith moderate
hemorrhage may have a.dd! tiortal advantages.

It has been

f01LiJ.d that cardie.,c outpu.t and oxygen consumption are more
rapio_ly increased by gi ying fluids contal:ning no red
cells in the initial treatment of shock.

T"h,is may be due

to decreased viscosity of the blood and better flo,,;

16.

characteristicsvlith hemo(lilution.

With

exsanc~uinating

hemo::Ft'hage, type 0 Rh-negative blood 'dith a
titer can be used immediately if needed.

lo,,~'

antibody

Several infusion

si tea ,11th large catheters and pu.mpir.,g devioes may be
required.
~'11:1ile

shock is bei11g tree.ted , definitive treatment of

the I'TOunds or sites of hemorrhage must be started.

It may

not be possible to achieve n01""tl1al cardiovasculclr function
j.f blood loss contimles.

Circulatory support must be

suffioient to maintain coronar-.1, cerebral, and renal
function vlhile the patient is transported to the operating
room or other suitable facility.
The treatment of blood loss is '!tiith blood trarJ.Sfusion,
but blood alone may not be the best replacement solution.
Saline solutions In addition seem to be helpful, sinoe there
seems to be an increased cape.city or increased requirement
of the c1.,rculation for blood volume to maintain pressure

21

and flow in late or severe shock.
The reasons for this
45
have been sumi'narized by Moore.
It has been hypothesized
that tl1.e increased sodiu..m speuce a,tld need for saline soluvt-

ions

111 th

trauma and shock may be from a take-up of sodi'llI'll

salts and Vlatel'" by extravascular-extracellular tissue such
as collagen and ground substance.

Ringer's lactate has

also been found helpful to the injured patient.

Shires

53

used Ringer's lactate solution initially in patients \i'!ith
hemorrhagic shock.

One or ti'10 liters given rapidly to

patients vlith marked hypotension often returned the blood

1 '7I •

pressure to normal..
also given..

If hemorl"'hage continued, blood 1:ms

One advantage to the use of RiT'4.:;er t s lactate

solution rathel" than isotonic saline is the prevention of
a fUl"'ther reduct:i.on in pH, vlhich occurs \dth s".:,-line, by buffer
d:t1ution in an already acidotic patient.

HOviever, the

question has been asked as to 'IThy give more lactc.te I,then
the blood lactate is already elevated in shoc}r..

Studies

have found that 1'lhen Rir'.L(,;erfs lactate solution is given to
an animal in shoc1r, the blood lactate level rapidly decreases
if blood flovr and cardiac output are improved.

The

excess levels of lactate quickly return to normal ..
f~>ihen

51+

blood loss is replaced I,ri.th electrolyte or

colloid solutions it is at the expense of reduction of
protein
capacity..

concentration, hema. tocrit, C'.nd oxygen-carryi:.t1.g
~"lere

is little kno'lln about the potential

difficulties of :protein cUlution except that edema. may result
due to hypoproteinemia.

It has been found that \'7hen blood

vollL'1le is restored 1;ri th RiT'..ger f s lactate solution, as
COml)ared ",lith blood, a marked. reduction in red cell mass
did not ir.hibit improvement

~Ln

oxidative metabolism.

Blood as commonly preserved. and stored in
bank is an unphysiologic solution.

11

54

blood

It is freql'tently

stored in aci.d-ci,trate-dextrose solut:lon, and 1iThen rece:i:ved
for use it is usually cold.

The pH ranges from 6.6 to 7,

;]cud there is no ionized cJ.lcium due to a 30

citrate.

%excess

of

The plasma potassium levels may also be elevated.

T:"1ese abnormalities present no 'orob1e111 1;\Then sma.ll quantit:tes

18.

of blood are given.

Oi trate can be rapiclly metabol:]"zed by

the liver to bicarbonate C'lnd calcium. is mobilized from
body stores.
fluids.

The potasSi1.;llU ls rapidly dlstr:i.buted in body

In patients requiring massive or contlnuir..e; blood

replacement, or "'iihere shock is complicated by hepatlc or
renal disease, c1 trate is not metabolized rap1clly and may
decrease ionized calcium.

Acidosis may be increased and

the body temperature reduced.

These abnormalities along

'\'lith hyperlr:alemia, may not only reduce ca.rdiac efficiency,
but ca.n produce c<:lrdi8.c arrest or ventricular fibrillation.
11

Bunker and his group

found blood citrate levels

sufficiently high to reduce 1.onized calciu.rrr in the blood
in patients i,dth hepatic disease or obstruction to hepatic
circulation l'iith multiple transfusions, or 1.11 any pa.tient
"lith extremely rapid or proloIltsed infusion of citrated
blood.

They also pointed out the difficulty of predictil'lg

\IThen thj.s vlOuId occur and the potenti'3.l dcl1lgers of using
calcium salts empirically.

R"1pid administration of calciu..1!l

ion can produce increased ventricular excital)ility and
ventricular fibrillation '\',rhich is accentuated by decreased
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temperature.

rv1ANNITOL
Mannitol is an agent frequently used in shock.
hE:,lpful in

protectiT'.{~

It is

the Iddneys and also in the diagnosis

of acute renal failure.
which is not metabolized.

Ma~~itol

is a six carbon alcohol

It is rea,dily filtered through

19.

the glomerulus, and is not reabsorbed in the rena,1 tllbu.le.
Even in patients i11th previously negligible urine output
a11a maxirna.l g,1!ticl1tll"")etic stim1). l~~ttion, it generally produces

an osm.ot:lc diuresis 'iri th urine pr'oductlon.

The functions of

mannitol 1/ih1ch are useful for the patient i11. f3hoclt: are a.s a
dis.gnostic test for acute renal fililure in the p8. t5. erlt

o11.guria or anuria, and
it ls threatened

t1S

t,r.t

a protection to the kidney \'i'hen

th acute tubular necros:ts from lschemla

!..lnd nephrotoxic sU.bstances such as hemoe;lob::Ln and myo310bin.
ra:pid intravenous

an

grams of

increase in urine flou -unless there is ;:'..cute ol"'Sclnic
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renal failure.

A lack ot respor..se to ttvo such infusions

ivi·thin three 110urs is a strong indic::,.ti.on of org"mic renal
failure or acute tubular necrosiS.

It Should be noted,

however, that "11th severe persistent hypovolemia, rnar":'1.itol
may not

~l.nduce

a diureSis u"'ntil this i.s partially corrected.

Plasma expanders (1.re colloid solutions \'ihich exert
a colloid osmotic or oncotic pl-'essure across the semipermeable capillary membrane and thus remain in the vascular
compartment for a prolonged period.

They may be necessar.:r

1'"/'hile blood is being prepared or secured si.nce the first
cOl~ideration

in restitution of normal volume is not the

infusion of red cells to increase oxygen-carrying capacity,

but, rather, the re-establisThT.ent of normal circulating

20.

volume.

Colloids effective as plasma expanders are

similar to albumin and should have a molecular ,veight
above 50,000 so that they do not leave the circulation
rapidly.

Dextran is currently stockpiled by the Al"'raed

Forces and is the only plasma expander presently
recomi11ended by the J:lational Research Council.

'1'he dextrans

are 10n13 chain polysacchal"'ides prepared by the grmrth of
B-512 strain of Leuconostoc mesenteroides.

They are

hydrolyzed to various molecular "'reights vii th the average
molecular weight being 78,000, and range of 1.1-5,000 to
180,000.

They are inexpensive, chemically indifferent,

and electrically uncharged.
vT.hen dextran is employed for plasma expanSion, and
trRl1....'3fusion of ''11101e blood is anticipated, it is necessaI"lJ
to dra11 blood fOl" typing and cross-matching prior to the
dextran infusion, as th.is substance Hill cause some
agglutiUc;ttlon of red cells on the slide or j.n the test
tube, making cross-matching difficult.

Use of large

volumes 0:1:" dextran may result in hemodilution, reduced
oxygen carrying capacity, and diminished

e~ithrocyte

bufferir~.

An increased bleeding tendency has been noted ,·lith

dextran, particularly 1rlhen large volumes ar'e given.

6
Bloom

found that a prolol1cr;ation of bleeding time Vii th

dextran

viaS

related to ex})ansion of the bloJd volume

rather than the level of dextran and noted that this
occurred ',ri th any plasma vall,liue expander.

Dilutj.onal

21e

hypoprothrombinemia, hypofibrinogenemia, and platelet
coating ;;.lith dextran may also playa part.

This plus

hemodilution limj.t the recommended tot,al dose to one to
t·wo liters.
Pooled plasma has been considered excellent for
emergency use as a volttrne expander.

Hmvever, processing

to elimi:tlate the hepatitis vir. .ls through storage or
heating have not proved completely effective.

For this

reason, the National Research Council Committee on Plasma
and Plasma Substitutes recommends that the use of' ,,,hole,
pooled human plasma be discoul"'aged or discontinued unless
a clear-cut reason can be cited for its unique requirements.
Human serum albumin "'Tould be excellent for volllil1e expansion,
but is almost never used for this purpose since it is
exper..sive and may not be as reacUly available.

Lmi MOLl:CCULAR I'lEIGHT DEX11RAN

The microvasculature consists of all vessels ot' 100
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microns or less ;tn size.

It consists of precapillary

arterioles, capillaries, and venules.

It is the part of

the circulation that is involved i.-lith cell nutrition.
Improvement of 1'lovf in this seqment of the vascular bed
is the primal:"lJ aim in the treatment of shock.

it

\1'8.6

Em-lever,

only T'ecently realized that changes 1.n the fluid

structure of blood with cell aggregation or sludged
blood could affect

flo'~l

in this com:partment.

Blood is

a viscid fluid, and in the microcirculation, vThere flm1
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may norrllally be SlOrJ or transiently stop, viscosity becomes
important.

LOvi molecular ,'leight or levi' viscous dextran

1:1ith an average molecular "J'eight of 40,000 1s of interest
because it seems to have a beneficial effect on the

25,39

microcirculat ion.
This effect of dextran of reversing cell aggregation
smd reducing blood viscosity seems to be ca1.lSed by
principal mechanisms.

t't1"O

One ls a rapid increase in plasma

vol11.'l1e by pulling interstitial liater into the Circulation,
11"hlch produces hemodl1uti.on and reduces blood viscosity.
The second is an influence on the red cell membrane by
coatiM it or altering the proteln envelope on aggregated

'"'7

cells.
The effects of lOitl molecular 1tleight dextran on
coagulation seem to be much the same as vd,th clinic:3,l
dextran.

There is some prolongation of

because of increased tissue blood flo"l.

bleedir~

time

Therefore, it

must be used 1dth caution or avoided in patlents

'I'J110

are

bleeding or mig'ht be bleeding" particularly if mechanical
hemos tas is 1 s not poss i ble •

The final role of 1mV' molecular

,,;reight dextran in the treatment of shock has not been
deter.ninec1, but it has proved to be an interesting
rheologic agent and h'?s stimUlated an entire field of
vrorthwhile investigation.

OXYG,EN AND VE~NTIU~rORY ASSISTAl\fCE

One of the primary defects in shock is a reduced

23.

oJC",fgen supply to the tissues.

Empirically, oxygen

seem to be indicated for all patients in shock.

'\1011.10.

Hmiever,

in the patient in shock 'I'lith satisfactory ventilation,
artel"'ial oxygen saturat:1. on viill be nOl''mal, and tissue
orjger..ation can only be :i.mproved by increasing blood
flm'i and oxygen delivery.

It is necess8.ry to be certa:i.n

that ventilation is adequate.

Airl<iay obstruction and

inadequate ventilation require correction by endotracheal
intubation, tracheostomy, or positive pressure ventilation.
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Measurement of arterial blood gases and pH are necessary to determine carbon d:toxide retention, hypoxemia,
or acidosis which may precipitate or contribute to
59
unresponsive shock.
'flh.en pH is less that 7.35 and PC02
exceeds 46 rom Hg, the patient has respiratory acidosis.
For practical purposes, v1hen the P02 in arterial blood is
less than 70 In.-rn Hg (93% saturat ion), oxygen exchange i.s
def'ective.

Respiratory aci()osis usually indicates either

airway obstrL1ction or inadequate bellol'J"S action because of
neural, muscular, or mech[-3.nical defic:l.t.

r.1echanical

assj. st.ance of venti.lation is usually needed.

A sharp

decline in oxygen tension or saturation usually indicates
shunting through collapsed or cO!l...solidated lung.

If this

shunting effect is not promptly resolved after 'clearing
obstr-actions or by mechani.cal ventilation, the concentJ:'ation
of oxygen in inspired ai.:r should be increased to ll·O% or
greater.

After 0:1.73en content of a,rterial blood re"whes

normal levels, is chemic injury to orgO:3,118 IJ.no. vi tE'_l tissues,
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:1. no luding the heart, is m:i.nimized.

VASOPRESSOR AND VASODILATOR AGEN"'TS

Sympathomimetic drugs are "!'V'idely used by most clinically
active physicians.

Effects of thes drugs comprise

4

broB.d types: cO!l..stricti.on and dilation of resistance and
capacitance vessels; inotropic eJld chronotropic actior.J3;
metabolic effects, such as glycogenolysis and lipolysis;
end central nervous system stimulation.
dr~gs

Sympfttholytic

block one or more of these responses.
Vasopressor or constrictor

(Levopbed),

meta~-.J!!inol

dr~gs

such as levarterenol

bitartrate (Aramine), and

phenylephrine (Neosynephrine) have frequently been used
in the treatment of shock, lX:l.rtlcularly 'dhen blood, fluids,
and other measures do not raise the blood pressure to a
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satisfactory level.

-

Such agents are practically

ali-laYs effective in elevat. i.ng the blood pressure, at least
transiently, even though the patient may ultimately not
sUJ':"'.r:lve.

There has been a fixation of the arterial blood

pressure in shock, a.nd frequent ly the blood pres sure
been treated rather than the patient.

11.<':1S

Hovlever, this

situation is nov; rapidly changing because of the knm·.rledge
that increased or prolonged vasoconstriction :may be harmful
and because of the availability of drugs irlhich vIi11

12
increase blood :flo'!", rather than blood pressure.
in 1923 vlrote that increased arterial pressure

Cannon
vTaS

not

vJho,t vias needect in shock, but ra.ther the need vms for

increased capillary blood flovl.
Srmpathetic nervous system receptors may be divided
into stimulatory or

,!:tlph~-?~

receptors Hhich produce

vasoconstrict.ion and per:tpheral :Lnhibiting or beta

13

receptors vJ'h:l.ch vasodilate.

Cardiac receptors are all

stimulatory and are beta receptors 'V1hich increase
contractility, i.e., inotropic and rate chronotropic.
Norepine~)hrine

and

metar~'Uinol

are alpha-stiJlmlatiJ:1..g

drugs in the periphery, :l.ncreasing resistance, and beta
st.imulati~3

rate.

for t.he heart, increasing contractility and

Phenylephrine increases resistance 'irith only a weak

effect on the heart.
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Methoxamine r...ydrochloride

(Va-soxyl) I.:lnd a.:ngiotensin II (Hypertensin) are pure
alpha-stimulating dra.gs 1-lith no direct effect on the
heart.. E-pinephrine (AdrenB.lin) has both alpha. and beta
st1l11ulating effects \'i'hlch generally increase resistance
and stimulate the heart.

Iso:qroterenol hydrochloride

(Isuprel hydrochloride) and mephentermine sulfate (\vyamine
sulfate) are pure beta-stimulating ctrt'l.gs \1'h:1.ch vasodilate

13

per1.pherally and stimulate the heart.

Other classes

of vasodilator agents are the alpha adrenergic blocking
l3,.7

agents

such as phenoxybenzamine hydrochloride (Dibenzyline)

and ganglionic blocking agents such as trimethaphan
cemsylate (Arfonad

c8~sylate).

In traumatic or hemorrhagic shock, there is only one
potential phYSiologic indication for the use of vasoactive
agents, and that is for temporary elevation of a markedly
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reduced blood pressure ;"rhich might produce cardiac arrest
l"')efore blood and fluids can be given.

Even then, a fe11'

hundred milliliters of saline solution viill usually begin
to elevate the blood pressure.
The sig!l..ificance of studies of blocking agents
or vasodilators has been difficult to interpret in hemorrha51c shock because of decI'eased blood los s vlhen the
agent is given before the shock and the necessity to
restore blood volume if such agents are given

duri~~

shock.

The beneficial effect of these agents has been thought to
be due to reversal of the loss of plasma volu.,'ne produced
by vasoconstriction, decreased res:1.stsmce with improved

blood flow' to tissues, and a decreased vlork load of the
heart.

38
Lillehei

has been one of the pioneers in the study

and clinical use of phenoxybenzam:Lne hydrochloride in
shock "fhen volume replacement has not produced improvement,
and has reported clinical improvement and survival in
otheI'1vise unrespor!.S ive patients.

He stresses the importance

of adequate blood volume replacement v;i'th the use of the

ctrug, vihich is given in a dose of one milligram per
kilogram intravenously over all hour period.

of

- 20

the drug per'Sists for about 24 hO'lJ.rs.

""
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MacLean

in studies of' sever'e or unrespor...sive shock

in man, found that isoproterenol
1111.en volume

l ....eplacement

pressure b'. .1t not

lilas

the dru.g of choice

11£:1d elevated the central venous

im~)1"oved

arterial PreSBure and.

cardi~lc

output.

Isoproterenol has a marked ct'lrdiac inotropic
22

effect, increlStses heart rate, and prod:"1".1ces vasodilatation.
HOi'leVer, \';hen it is given to the

~oatient

h1. shock ,'d th a

high C611.tral venous pressure, blood pressure ,,!ill frequently
rise because of the iml')roved cardiac output.

One to t\10

milligrams in 500 milliliters of dextrose and '1:Iater is
g:i.ven at a slm-7 rate not exceeding 15 to 20 drops per
minute.

Tachycardia may be a problem and careful

titr,9,~"ion

is necessary.
In summary it may be said that the use of vasoconstrictor
agents viill probably decrease in the treatment of shock
and that the vasoactive agents of' choice 1rrill be drugs
such as isoproterenol for patients u.nresponsive to volume
replacement IOtnd other measures.
e~gents

The use of vasoactive

is unsound if blood volume has not been adequately

replaced as evidenced by central venous pressure

measurem~:mt.

lim'lever, they may be neceasary for short term use '\"lhen a
fall in blood presaure has been so sudden 13.nd severe that
arrest is iu"1r!linent.

III

this instance a vasopressor

agerrG may be lifesaving until fluids or blood can be given
and other problems corrected.

~mTABOLIC

ACIDOSIS

In shock there 1s a decreased carbon dioxide content
of the blood.

This

'liaS

first confirmecl in vlorld "iie,r !

12
casualt:i.es by Ca:n'1.on.
..

The metabolic acidosis produced

during severe shock by cell :b.yPOXl,a., anaerobic glycolysis,

28.

and increased acid metabolites

been thought to be

rillS
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harmful and to further depress the circulation.

As

previously noted, the most iml;ortant problem caused by
acidosis in the human m.e.y be the propensity to cardiac
arrest or ventricular fibrillation.
The arterial pH in patlents in shock may be as lov;/, as

7.1, but is more frequently at levels of 7.25 to 7.35
because of respiratory compensation.

SodiU!l1 bicarbr.)nate

is the most available and useful alkal:i.nizing agent for
treatment of acidosis, and some use it empirj.cally in all
patients vlith severe shock.

Frequently this is not

necessary, and documentation of the pl"oblem by measurement
of pH and bicarbonate concentration or pC02 of arterial
blood should be obte.ined vlhenever possible.

Since large

amou,"0.ts of sodium blc8.1"bol1.ate 1'Jith sizable sOdi.1.L'11 and
1tlater loads may be necessary to correct grossly abnormal
pII,

ft

more potent bufferi,n.e; agent, Tl1all or ffris b'uffer

(tromethamine) r.tas been studied.

It has the ability to

penetrate cells, but v'ihether this intracellular buffering
is advantageous is not knovln.

It is, hmvever, a potent

hydrogen ion acceptor and has the distinct a.dvantage of
su·pplyj.ng buffer vlithout sod:i.llill ion.
of promoting osmotic diuresis.

It is also cap;3.ble

Respiratory delJression

is COIrL11l0n, and ventilatory support must be avai.loble. In
a recent revie\·,r, Bleich 8.nd Schv18rt z

5

found

nothir~

to

recommend Th-3..111 over sodium bicarbonate in the treatment
met.a.bolic acidos is.

Hence, tb.e plE'l.ce of Them in the

treatment of shock is not definitely established, but it
may be of some use.

STJi:ROIDS
Hemorrhagic shock may develop in patients 1,ij.th adrenal
ir...sufficiency or those previously receiving steroids.
Since a rare patient may have aClJ.te adrenal corM. cgl irtsui'ficiency in such a situation and can be resuscitated by
small doses of steroids, this empirical approach cannot
be condemned in a desperate situation.

.fA

plasma sample

for later corticosteroid determination may be helpful in
proving the deficiency state.

The use of massive doses of

steroids in some forms of shock: has become COill..!'Tlon practice,
but ",rill not be reviev16d here.
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OffHER CONSI DERi'~:rI ONS

Dip;it,'3.lis.

The physician treatir..g a l:'atient "d.th high

centr,'Jl venous pressure and inadequate cardiac output should
consider the use of digitalis.

Digitalization :i"s justi.fied

in any patient in shock refract or"'" to fluid therapy,
beta inotrOIJ:lc c8.1""<1iac stimulants, and alpha adrenolytic
agents.

Digit,,,.lis preparat:tons are synergistic with

iso:proterenol.
Hy"Ootherrnia.

13
The potential usefulness of hypothermla h1

the treatment of shock has been demonstro"ted.

lL.'1

exponential

fall tn oxygen consumption occurs \'iith decreas:i. rl\:3 body
temperature indicating a decreased demand for oxygen by

30.

by cells.
Tv'!Q

11.19\1191"

Hypothermia, however, 11:'2_S not been used extensively.
methods for reducing cellular oxygen demand

are intravenous infusions of hypertonic glucose and
magnesiUt'll.

Neither method has had clinical application,

b"l1t the concept of i11duci:ng a state of reduced oxygen demand

13

may playa role in the 1"uture treatment of shock.
Poai tion of the Patient.

The Trendelel1burg pos1.tion has

been used to treat shock, but vital capacity is decreased.
The only reason

for its use is to empty the ve:1.n8 of the

legs, which may be the equivalent of a
transfusi.on.

si~~le

blood

This can be qUi.ckly accomplished by raisir'..g

the legs alone.

Observations obtained from careful, partially controlled
stUdies in humans vdth major bleedir..g have changed sorne
classic concepts of shock management.

The patient in

shock must be observed by measurement of arterial blood
pressure, urine output, and central venous pressure, in
addition to general observations including skin color and
capillary circulation.

EssentiE'cl laboratory studies for

the d:iff'icult problem include determinations of serum
electrolytes and aterial blood pH, p02' and pC02 • Restoration and maintenance of an effecti va circulatin,g blood
vo1t:llUe should be carrieQ out us:lng 1;lho1e b1ood, clinical
dextran, saline, or Ringer's lactate solution.

The use

of saline solutions in add:ltion to blood may be helpful.
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If arterial l)reSSUre and ur'i.ne output do not respond
satisfactorily to volume replacement and central venous
pressure rises, drugs iilhi.ch increase myocardial contractility
such as isoproterenol and digitalis, should be consi.dered.
D~ugs

which produce vasoconstriction and i.ncrease myocardial

contractility such as norepinephrine or aramine must be
used cautiously in attempts to produce pri.marily an
inotropic effect on the heart.
Improvement of alveolar ventilation, correction of
metabolic acidosis, and replacement of continuing losses
of blood -and fluids may be critical.

Mannitol seems to

be helpful in protecting the kidneys, and low molecular
ille::tght dextran may help in 1..mproving blood flol'! :i.n the
microcirculation.

The most frequent causes of lack of

responsiveness to treatment are unrecognized volume
deficits or continuing losses of blood volume, inadequate
replacement of losses, myocardial fai.lure, severe sepsis,
peripheral poolir;.g of blood volume, iJ:"l..8,dequate ventilation
v'Tith hypoxia or carbon dioxide retention, or both,
pel"sistent metabolic aCidosis, hyponatremia, hyperlcalemia,
hypocalcemia, and renal failure.
Measures directed at decreasing peripheral resistance,
increasing cardiac output, and providing support for lu:ng
'-.lnd kidney should be included in the treatment.

Iv1onitorir..g

techniques have increased in sophistication, but intelligent,
careful, minute-to-m:tnute bedside observation remains the
most importa:n:t. guide in care of the shock pa.tient.

32.
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